Earnings call Novartis reported Q1 2025 sales growth of 15% YoY and core operating income growth of 27%, with core EPS up 31% to $2.28. Strong brand performance and cost discipline drove a 400bps ...
Earnings call Novartis reported Q2 2025 sales growth of 11% YoY and core operating income up 21%, with a 340 bps core margin expansion to 42.2%. Core EPS rose 24% to $2.42. Management raised FY25 core ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback